SHR-1707 is a humanized anti-Abeta IgG1 monoclonal antibody. SHR-1707 binds Abeta fibrils and monomers, blocking plaque formation and promoting the microglial phagocytosis of Abeta. SHR-1707 reduces brain Abeta deposition in 5xFAD transgenic mice. SHR-1707 can be used for Alzheimers disease research. Recommend Isotype Controls: Human IgG1 kappa, Isotype Control (HY-P99001)[1].
Target:
Amyloid-beta
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted
